跳至主要内容
临床试验/KCT0007080
KCT0007080尚未招募未知

A Multicenter and prospective observational study to evaluate the effectiveness and safety of Rosuzet Tablet in patients with acute ischemic stroke

Chonnam National University Hospital0 个研究点目标入组 1,500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • 1) patients with acute ischemic stroke or transient ischemic attack with positive DWI lesions within 72 hours of onset and starting treatment with rosuzet within 3 days after admission; 2) one of following a to d items, a) previous station or ezetimibe treatment, b) previous atherothrombotic diseases, needed to statin or lipid lowering agents, c) dyslipidemia, d) admission LDL-C >70 mg/dl; 3) patients signed informed consent

排除标准

  • 1) contraindications of rosuzet, (1) sensitivity to rosuzet (rosuvastatin or ezetimibe), (2) active liver diseases, (3) muscle diseases, (4) cyclosporin treatment, (5) severe chronic kidney disease; 2) pregnant women or breastfeeding; 3) ineligible for the study

研究者

相似试验